Swiss National Bank
TEVA icon

Swiss National Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$60.6M Buy
3,616,500
+486,100
+16% +$8.15M 0.04% 384
2025
Q1
$48.1M Buy
3,130,400
+2,500
+0.1% +$38.4K 0.03% 415
2024
Q4
$68.9M Sell
3,127,900
-215,000
-6% -$4.74M 0.05% 333
2024
Q3
$60.2M Buy
3,342,900
+15,300
+0.5% +$276K 0.04% 385
2024
Q2
$54.1M Sell
3,327,600
-17,200
-0.5% -$280K 0.04% 385
2024
Q1
$47.2M Sell
3,344,800
-156,900
-4% -$2.21M 0.03% 440
2023
Q4
$36.6M Sell
3,501,700
-122,100
-3% -$1.27M 0.03% 510
2023
Q3
$37M Sell
3,623,800
-360,500
-9% -$3.68M 0.03% 486
2023
Q2
$30M Sell
3,984,300
-417,100
-9% -$3.14M 0.02% 570
2023
Q1
$39M Sell
4,401,400
-108,600
-2% -$961K 0.03% 522
2022
Q4
$41.1M Sell
4,510,000
-206,093
-4% -$1.88M 0.03% 491
2022
Q3
$38.1M Buy
4,716,093
+27,700
+0.6% +$224K 0.03% 516
2022
Q2
$35.3M Buy
4,688,393
+31,700
+0.7% +$238K 0.02% 539
2022
Q1
$43.7M Buy
4,656,693
+353,300
+8% +$3.32M 0.02% 532
2021
Q4
$34.5M Sell
4,303,393
-249,900
-5% -$2M 0.02% 573
2021
Q3
$44.3M Sell
4,553,293
-115,000
-2% -$1.12M 0.03% 527
2021
Q2
$46.2M Buy
4,668,293
+347,894
+8% +$3.44M 0.03% 532
2021
Q1
$49.9M Buy
4,320,399
+98,100
+2% +$1.13M 0.03% 492
2020
Q4
$40.7M Sell
4,222,299
-102,300
-2% -$987K 0.03% 520
2020
Q3
$39M Sell
4,324,599
-77,400
-2% -$697K 0.03% 484
2020
Q2
$54.3M Buy
4,401,999
+94,500
+2% +$1.17M 0.05% 381
2020
Q1
$38.7M Buy
4,307,499
+486,000
+13% +$4.36M 0.04% 410
2019
Q4
$37.5M Sell
3,821,499
-207,600
-5% -$2.03M 0.04% 446
2019
Q3
$27.7M Buy
4,029,099
+44,000
+1% +$303K 0.03% 513
2019
Q2
$36.8M Buy
3,985,099
+413,800
+12% +$3.82M 0.04% 445
2019
Q1
$56M Buy
3,571,299
+37,200
+1% +$583K 0.06% 320
2018
Q4
$54.5M Buy
3,534,099
+31,300
+0.9% +$483K 0.07% 280
2018
Q3
$75.5M Sell
3,502,799
-184,100
-5% -$3.97M 0.08% 251
2018
Q2
$89.7M Buy
3,686,899
+298,600
+9% +$7.26M 0.1% 212
2018
Q1
$57.9M Sell
3,388,299
-135,200
-4% -$2.31M 0.07% 292
2017
Q4
$66.8M Buy
3,523,499
+32,000
+0.9% +$606K 0.07% 282
2017
Q3
$61.5M Buy
3,491,499
+17,900
+0.5% +$315K 0.07% 290
2017
Q2
$115M Buy
3,473,599
+33,448
+1% +$1.11M 0.14% 163
2017
Q1
$110M Sell
3,440,151
-190,100
-5% -$6.1M 0.14% 166
2016
Q4
$132M Buy
+3,630,251
New +$132M 0.21% 108